However, both noggin and β-estrogen can rescue this phenotype, suggesting apoptosis mediated by OPA1 mutations plays an important role in the pathogenesis of optic atrophy, and noggin and β-estrogen could be potential therapeutic agents. Here, NOG is linked to Leber hereditary optic neuropathy.